Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Clinical trial NCT03288129 · COMPLETED
Trial details
- NCT number
- NCT03288129
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-23
- Primary completion
- 2021-04-27
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.